Pfizer's Abrocitinib Looks Competitive In Atopic Dermatitis

Women scratch the itch with hand , Concept with Healthcare And Medicine. - Image
Abrocitinib appears to rapidly reduce itching, a hallmark of AD. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D